These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Expression of Beclin-1, an autophagy-related marker, in chronic hepatitis and hepatocellular carcinoma and its relation with apoptotic markers. Al-Shenawy HA. APMIS; 2016 Mar; 124(3):229-37. PubMed ID: 26756998 [Abstract] [Full Text] [Related]
23. Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells. Kim HJ, Lee SG, Kim YJ, Park JE, Lee KY, Yoo YH, Kim JM. Int J Oncol; 2013 Jun; 42(6):1985-92. PubMed ID: 23563171 [Abstract] [Full Text] [Related]
24. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53. Zhang C, Feng Y, Qu S, Wei X, Zhu H, Luo Q, Liu M, Chen G, Xiao X. Cardiovasc Res; 2011 Jun 01; 90(3):538-45. PubMed ID: 21278141 [Abstract] [Full Text] [Related]
25. The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models. Zhu YR, Zhou XZ, Zhu LQ, Yao C, Fang JF, Zhou F, Deng XW, Zhang YQ. Oncotarget; 2016 Aug 02; 7(31):49527-49538. PubMed ID: 27385099 [Abstract] [Full Text] [Related]
26. Xiao Jin Wan, a traditional Chinese herbal formula, inhibits proliferation via arresting cell cycle progression at the G2/M phase and promoting apoptosis via activating the mitochondrial‑dependent pathway in U-2OS human osteosarcoma cells. Wu G, Chu J, Huang Z, Ye J, Chen P, Zheng C, Li X, Liu X, Wu M. Int J Oncol; 2013 Mar 02; 42(3):1070-80. PubMed ID: 23354363 [Abstract] [Full Text] [Related]
27. Methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate (HIMOXOL), a synthetic oleanolic acid derivative, induces both apoptosis and autophagy in MDA-MB-231 breast cancer cells. Lisiak N, Paszel-Jaworska A, Bednarczyk-Cwynar B, Zaprutko L, Kaczmarek M, Rybczyńska M. Chem Biol Interact; 2014 Feb 05; 208():47-57. PubMed ID: 24291674 [Abstract] [Full Text] [Related]
28. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins. Gonçalves C, Martins-Neves SR, Paiva-Oliveira D, Oliveira VE, Fontes-Ribeiro C, Gomes CM. Life Sci; 2015 Jun 01; 130():47-56. PubMed ID: 25818183 [Abstract] [Full Text] [Related]
30. Autophagy prevents doxorubicin‑induced apoptosis in osteosarcoma. Zhao D, Yuan H, Yi F, Meng C, Zhu Q. Mol Med Rep; 2014 May 01; 9(5):1975-81. PubMed ID: 24639013 [Abstract] [Full Text] [Related]
31. Lycopene protects against apoptosis in hypoxia/reoxygenation‑induced H9C2 myocardioblast cells through increased autophagy. Chen F, Sun ZW, Ye LF, Fu GS, Mou Y, Hu SJ. Mol Med Rep; 2015 Feb 01; 11(2):1358-65. PubMed ID: 25351505 [Abstract] [Full Text] [Related]
32. Autophagy plays an important role in sunitinib-mediated cell death in H9c2 cardiac muscle cells. Zhao Y, Xue T, Yang X, Zhu H, Ding X, Lou L, Lu W, Yang B, He Q. Toxicol Appl Pharmacol; 2010 Oct 01; 248(1):20-7. PubMed ID: 20637791 [Abstract] [Full Text] [Related]
33. Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity. Pizarro M, Troncoso R, Martínez GJ, Chiong M, Castro PF, Lavandero S. Toxicology; 2016 Aug 31; 370():41-48. PubMed ID: 27666003 [Abstract] [Full Text] [Related]
34. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity. Fan GC, Zhou X, Wang X, Song G, Qian J, Nicolaou P, Chen G, Ren X, Kranias EG. Circ Res; 2008 Nov 21; 103(11):1270-9. PubMed ID: 18948619 [Abstract] [Full Text] [Related]
35. Autophagic dysregulation in doxorubicin cardiomyopathy. Bartlett JJ, Trivedi PC, Pulinilkunnil T. J Mol Cell Cardiol; 2017 Mar 21; 104():1-8. PubMed ID: 28108310 [Abstract] [Full Text] [Related]
36. The autophagic response to nutrient deprivation in the hl-1 cardiac myocyte is modulated by Bcl-2 and sarco/endoplasmic reticulum calcium stores. Brady NR, Hamacher-Brady A, Yuan H, Gottlieb RA. FEBS J; 2007 Jun 21; 274(12):3184-97. PubMed ID: 17540004 [Abstract] [Full Text] [Related]
37. Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance. Robinson P, Kasembeli M, Bharadwaj U, Engineer N, Eckols KT, Tweardy DJ. Biomed Res Int; 2016 Jun 21; 2016():1959270. PubMed ID: 26981525 [Abstract] [Full Text] [Related]
38. Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination. Chen B, Zhang JP. Phytomedicine; 2022 Jul 21; 101():154130. PubMed ID: 35526324 [Abstract] [Full Text] [Related]
39. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma. Kamata E, Kawamoto T, Ueha T, Hara H, Fukase N, Minoda M, Morishita M, Takemori T, Fujiwara S, Nishida K, Kuroda R, Kurosaka M, Akisue T. Anticancer Res; 2017 Nov 21; 37(11):6097-6106. PubMed ID: 29061790 [Abstract] [Full Text] [Related]
40. SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition. Wang W, Chen D, Zhu K. J Exp Clin Cancer Res; 2018 Feb 23; 37(1):37. PubMed ID: 29475441 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]